SurModics (SRDX) Tops Q3 EPS by 98c, beats revenue

SurModics (NASDAQ: SRDX) reported Q3 EPS of $0.52, $0.98 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $52.5 million versus the consensus estimate of $26.27 million.

For earnings history and earnings-related data on SurModics (SRDX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Is Treasury selloff a major issue for stock market bulls?
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c